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Abstract: The distribution of glutamate (Glu), the Glu transporter GLAST-1, and glutamine 
synthetase (GS) in human and monkey anterior uveal tissue, as well as serum (S) to aqueous humor 
(AH) Glu and glutamine (Gln) gradients were investigated. Cross-linked Glu (xGlu), 
GLAST-1, and GS were detected using the immunoﬂuorescent antibody technique. S/AH 
Glu, Gln, and alanine (Ala) concentrations were quantiﬁed by high performance liquid 
chromatography. xGlu immunoreactivity was detected in melanocytes, posterior pigmented 
epithelial/dilator muscle cells, vascular endothelial cells, and lymphocytes of the iris, as well 
as the pigmented (PE) and nonpigmented epithelial (NPE) cells and muscle cells of ciliary 
body. xGlu immunoreactivity was highly concentrated at the apices of GLAST-1, GS positive 
ciliary body NPE cells, and in GLAST-1 positive iris melanocytes and iris dilator muscle 
cells. AH Glu concentrations were lower (p < 0.001), while Gln was higher in monkey (p 
= 0.01) and human cataractous (p = 0.15) AH than serum. The results indicate that Glu is 
concentrated within GLAST-1, GS positive NPE cells and are consistent with the suggestion 
that Glu and Gln concentrations in AH may be due in part to GLAST-1 and GS activity in 
iris and ciliary body epithelial cells.
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Introduction
Cells within ocular tissue, as well as other tissues of the body, take up and utilize 
Glu for energy, protein, and nucleic acid synthesis. The cellular distribution of Glu, 
as well as several other amino acids, has been extensively mapped in zebraﬁ sh iris, 
ciliary body, and retinal tissues (Marc and Cameron 2001) and in primate and feline 
retinal tissue (Kalloniatis et al 1996; Marc et al 1998). Notably, some cells contain 
high concentrations of Glu (Ehinger 1977; Davanger et al 1991; Kalloniatis et al 1996; 
Marc and Cameron 2001). Moreover, uptake and metabolism of Glu by retinal cells is 
essential for normal retinal function. Accordingly, the uptake of extracellular Glu by 
the high afﬁ nity Na+/K+-dependent excitatory amino acid transporters (EAAT) (for 
review see Arriza 1994; Kanai et al 1994; Schultz and Stell, 1996; Lehre et al 1997; 
Arriza et al 1997; Lim et al 2005) is critical to glutamatergic function, preventing the 
neurotoxicity caused by over-stimulation of the Glu receptor by elevated extracellular 
Glu levels (Choi et al 1987) and regulating gap junction communication between glia 
and astrocytes (Enkvist and McCarthy 1994). Further, it has been suggested that the 
rapid uptake of Glu by GLAST-1 (EAAT-1) and conversion to Gln by GS (converts 
Glu plus ammonia to Gln) in retinal Müller cells (Riepe and Norenberg 1978; Rauen 
et al 1998; Shen et al 2004) protects against Glu neurotoxicity, inhibits ammonia 
neurotoxicity (Derouiche and Rauen 1995; Shaked et al 2002), and regulates glial 
cell swelling (Izumi et al 2004). Notably, GS is the only intracellular enzyme that 
can convert Glu to Gln and is highly concentrated in organs that appear to function Clinical Ophthalmology 2007:1(1) 44
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primarily to remove Glu or ammonia (van Staaten et al 
2006). Concomitantly, the accumulation of Glu in retina 
and lens (Reddy 1967) and the lower than plasma concen-
trations (20 μM) of Glu in AH and vitreous humor of most 
mammalians (Reddy 1967; Reddy et al 1977; Wuu et al 
1988; Dreyer et al 1996; Wamsley et al 2005) suggest Glu 
is actively removed from the AH and vitreous.
The distribution of acidic amino acid transporters (ie, 
EAATs) in anterior uveal tissues, especially the PE and 
NPE cells of the ciliary body and posterior iris, is unknown. 
However, it is well known that Glu and other amino acids 
are actively transported across the ciliary body into the 
AH (Reddy 1967; Reddy et al 1977) and are taken up and 
utilized by the lens (Jernigan and Zigler 1987; Jernigan 
1990; Lim et al 2005). The results of previous studies 
have demonstrated EAAT expression in rabbit ciliary 
body tissue and have suggested that inhibition of the Glu 
transport elevates AH Glu levels and increases paracellular 
permeability of the blood – aqueous barrier (BAB) epithe-
lium (ie, passage of serum protein between ciliary body 
epithelial cells) (Langford et al 1997; 1999). The modula-
tory effect of Glu on the paracellular permeability pathway 
is also supported by in vitro studies showing that inhibition 
of extracellular Glu generation or high-afﬁnity Glu transport 
decreases the accumulation of Glu (Meade et al 1998) and 
increases epithelial cell monolayer paracellular permeability 
(Welbourne et al 1996).
The following immunohistological studies were 
performed to determine the distribution of xGlu immunoreac-
tivity in human and monkey iris and ciliary body tissues. 
In addition, the co-localization of GLAST-1 (EAAT-1) and 
GS with xGlu immunoreactivity was determined in human 
ciliary body tissues. Lastly, the serum to AH concentra-
tion gradients for Glu and Gln, as well as alanine (Ala), in 
humans and monkeys were assessed. The results show xGlu 
and GLAST-1 immunoreactivity in epithelial, endothelial, 
and muscle cells of iris and ciliary body tissue. Notably, 
high concentrations of xGlu immunoreactivity were detected 
at the apical surface of GLAST-1 and GS positive ciliary 
body NPE cells. Concomitantly, the concentration of Glu 
was lower while the Gln concentration was higher in AH 
than serum.
Materials and methods
Tissue samples
Three nondiabetic, phakic human cadaver eyes were 
obtained on ice from the Northwest Louisiana Eye Bank 
(Shreveport, LA) and processed for histological analysis 
upon arrival (Table 1). A venous blood sample (0.2–2.5 ml) 
and an AH sample (25–85 μl from the anterior chamber) was 
collected from 18 consenting adults during intraoperative 
cataract surgery. The experimental protocols were approved 
by the LSU Health Sciences Center Internal Review Board 
for the Protection of Human Research Subjects and were 
performed in accordance with the tenets of the Declaration 
of Helsinki.
AH and venous blood samples were collected from 
5 adult rhesus monkeys within 15 minutes of euthanasia 
(Macaca mulatto; Dr Louis N. Martin, Tulane Regional 
Primate Research Center, Tulane University Medical Center, 
Covington, LA) and placed on ice. One eye from two 
monkeys was excised within 30 min of death and processed 
for histological analysis as per human eyes. AH and blood 
samples were centrifuged (5,000Xg for 3 min) to remove 
cellular components and the AH and serum processed 
for amino acids quantiﬁcation or stored at –100 °C. The 
experimental protocols were approved by the LSU Health 
Sciences Center and Tulane Regional Primate Research 
Center Animal Care and Resources Committees and were 
performed according to NIH statement for the Care and Use 
of Laboratory Animals in Research.
Histological sections
Two 0.5X1.0 cm bands composed of cornea rim (1–2 mm) 
and sclera with attached iris, ciliary body, and retina were 
removed quickly from 3 human cadaver and 2 monkey 
eyes. The excised tissue was gently rinsed in cold phosphate 
buffered saline (PBS) and ﬁxed for 30 min in cold 0.4% 
paraformaldehyde, placed in Tissue Tek® O.C.T. embedding 
media (Miles, Inc., Elkhart, IN) and frozen (–100 °C). 
Serial cryostat sections were cut, placed on glass slides, and 
air-dried as previously reported (Langford et al 2006). Slides 
were stored dry at –20 °C until used.
Immunoreagents
Rabbit antibodies raised to cross-linked Glu (anti-xGlu) 
were purchased from Chemicon International (Temecula, 
CA; www.chemicon.com) and Signature Immunologics 
(Chromatag E30-Red; www.immunologics.com). Polyclonal 
goat anti-GS antibody (ab6585) was purchased from Abcam, 
Inc. (Cambridge, MA). Guinea pig polyclonal antibody to 
C-terminal peptide of rat GLAST-1 was purchased from 
Chemicon. Secondary antibodies used included TRITC-
tagged goat anti-rabbit immunoglobulin G (IgG) (absorbed 
with human IgG) (Sigma, St Louis, MO), FITC-conjugated 
goat anti-rabbit IgG (Fab’) (Cappel; Organon Teknika Corp., Clinical Ophthalmology 2007:1(1) 45
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West Chester, PA), FITC-labeled rabbit anti-goat IgG 
(Cappel) and FITC-tagged goat anti-guinea pig IgG (Sigma). 
Horse-radish peroxidase (HRP)-linked anti-guinea pig and 
anti-goat IgGs were purchased from Jackson ImmunoRe-
search Laboratories (West Grove, PA).
Immunoﬂuorescent antibody assay
The immunofluorescent antibody (IFA) assay using 
polyclonal antibodies to xGlu, GLAST-1, and GS was 
performed as previously described (Chen et al 2005; 
Langford et al 2006). Brieﬂ y, double labeling studies for 
anti-xGlu immunoreactivity with GLAST-1 or GS were 
performed on duplicate uveal tissue sections from 3 human 
and 2 monkeys on three slides each. Sections were covered 
with 0.1 ml of PBS containing of 1:40 dilution of E30 Red-
tagged rabbit anti-xGlu antibody (ie, direct IFA) or with 0.1 
ml PBS containing onto 1:1,000 dilution of rabbit anti-xGlu 
polyclonal antibody (ie, for indirect IFA) and incubated in 
humidiﬁ ed atmosphere overnight at 37 °C. Unreacted pri-
mary antibodies to xGlu were removed by 6 rinses of PBS. 
Secondary antibody (1:1,000 dilution of TRITC-tagged goat 
antibody to rabbit IgG in PBS) was pipetted onto sections 
reacted with rabbit anti-xGlu antibody and incubated in a 
humidiﬁ ed atmosphere for 6 h at 37 °C. Unreacted second-
ary antibodies were removed by 6 rinses with PBS. For dual 
GLAST-1 and xGlu immunoreactivity IFA, a 1:100 dilution 
of guinea pig anti-GLAST-1 antibody was pipetted onto 
sections previously reacted with rabbit anti-xGlu antibody 
and TRITC-tagged goat anti-rabbit IgG secondary antibody. 
After incubation overnight at 4 °C, a 1:1,000 dilution of 
FITC-tagged rabbit anti-guinea pig IgG was pipetted onto 
sections and incubated in humidiﬁed atmosphere at 37 °C for 
6 h. For dual GS and xGlu immunoﬂuorescent IFA, a 1:1,000 
dilution of goat anti-GS antibody was applied to the sections 
previously reacted with E30 Red-tagged rabbit anti-xGlu 
antibody. After overnight incubation at 4 °C, unbound anti-
GS antibody was removed by 6 rinses of PBS. One-tenth ml 
of a 1:1,000 dilution of FITC-tagged rabbit anti-goat IgG was 
pipetted onto each section and incubated for 6 h at 37 °C. 
Concomitantly, control sections were incubated in PBS 
containing 1:1,000 dilutions of goat or rabbit serum, rinsed 
6 times, and reacted with TRITC and FITC-conjugated sec-
ondary antibodies. All slides were rinsed 6 times with PBS 
to remove unreacted secondary antibody. Excess PBS was 
blotted from the slides, cover slips were applied with IFA 
mounting media (Calbiochem), and all slides were stored in 
the dark at 4 °C. Immunoﬂuorescence was observed using a 
40x .60 N.A. plan ﬂuor objective on a Nikon Eclipse TE300 
inverted microscope with an epi-ﬂuorescence attachment, 
using a Chroma 83000 ﬁlter set with single band exciters for 
FITC (492nm/18x) or TRITC and R30 Red (572nm/23x) in 
the ﬁlter wheel and a stationary multi-band beam splitter and 
emission ﬁlter. Images were captured with a Photometrics 
Cool SNAPfx monochrome CCD camera controlled with 
Scanalytics IPLab software.
Western immunoblot analysis
Iris, ciliary body, and retinal layers (temporal, central, mid-
third) were micro-dissected from the cadaver eyes under a 
10X binocular microscope. Iris, ciliary body (CB), retinal 
pigment epithelial (RPE), and retinal nerve ﬁber layer (NFL) 
tissue (10 mg) was placed in 0.3 ml of lysis buffer (50 mM 
HEPES, 10 mM CHAPS [3-[(3-cholamidopropyl) dimeth-
ylammoniol]-1-propanesulfonic acid], 5 mM dithiothreitol, 
pH 7.4). The tissues were frozen, thawed, and centrifuged at 
15,000Xg at 4 °C for 10 min. The supernatant ﬂ uids were 
recovered into labeled vials, the protein concentrations were 
determined (BioRad Protein Assay) and each was diluted to 1 
mg/ml in lysis buffer containing 1mM PMSF (phenylmethyl-
sulfonyl ﬂuoride; Sigma). The proteins in each sample 
(5 μ/20 μl Laemmli sample buffer; BioRad) were separated 
by 1% sodium dodecylsulfate –10% polyacrylamide gel 
electrophoresis (PAGE) in Tris/Glycine/SDS running buffer 
(BioRad), and transblotted onto a Hypond-P polyvinylidene 
diﬂuoride membrane (Fischer Scientiﬁc). After overnight 
incubation with a 1:1,000 dilution of goat antibody to GS 
or 1:100 dilution of guinea pig anti-GLAST-1 antibody, 
the immunoreactive protein bands were visualized utilizing 
HRP-linked anti-guinea pig IgG or anti-goat IgG as previ-
ously described (Chen et al 2005). Protein standards were 
Table 1 Age, sex, cause of death, and past medical history for three nondiabetic, phakic human cadaver eyes
Eyes Age Sex Cause of death Past medical history PMDa
1 (OS) 82 F Cardiopulmonary arrest Parkinson’s disease 2
2 (OD) 78 F Cardiac arrest None 5
3 (OS) 74 M Cardiac arrest None 5
Note: aPMD, Postmortem delay; hours between the time of death and time of procurement and processing.Clinical Ophthalmology 2007:1(1) 46
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included in one lane of each gel run (Precision Plus Protein™ 
Dual Color Standard, BioRad).
Amino acid quantiﬁcation
Fifty microliters of each clariﬁed (ie, centrifuged at 5,000Xg 
for 5 min) AH and serum sample were immediately placed in 
50 μl of 10% trichloroacetic acid (to inhibit the conversion 
of Gln and Glu prior to analysis) (Fonseca-Wollheim 1990). 
Samples were stored at –100 °C until the concentrations 
of Glu, Gln, and Ala were quantiﬁed by high performance 
liquid chromatography as previously described (Langford 
et al 1997).
Results
Detection of xGlu immunoreactivity 
in human anterior uveal tissues by IFA
Anterior uveal tissue sections from 3 human cadaver eyes 
(Table 1) were reacted with anti-xGlu antibody and the 
xGlu immunoreactivity visualized in cells by IFA analysis 
(Figure 1). XGlu immunoreactivity was detected in anterior 
iris melanocytes, pigment containing epithelial cells/dilator 
muscle cells along the posterior iris surface, PE cells, and 
NPE cells of the anterior corona ciliaris (pars plicata) of all 
human ciliary body sections (Figure 1A, B). In addition, xGlu 
immunoreactivity was detected in iris and the ciliary body 
blood vessels, lymphoid cells, and human ciliary muscle. 
High concentrations of xGlu immunoreactivity were local-
ized to PE and NPE cells (Figure 1 C–F). Notably, xGlu 
immunoreactivity was concentrated at the apical surfaces 
of NPE cells and was juxtaposed to the apically localized 
pigment granules in the PE cells (Figure 1E, F). The pos-
sibility that disease, post mortem changes, and melanin pig-
ment may affect the distribution of the xGlu signal within a 
tissue or cell cannot be discounted. In contrast, very weak 
immunoﬂuorescent staining for immunoreactive xGlu was 
detected in the interstitial tissue between the capillary blood 
vessels and the ciliary epithelial cells (Figure 1F). A simi-
lar distribution of xGlu immunoreactivity was observed in 
columnar NPE cells and cuboidal PE cells of the pars plana 
(posterior obicularis ciliaris). Also, high concentrations of 
xGlu immunoreactivity were detected at the apical surfaces 
of many of the columnar NPE cells (Figure 1G, H). In addi-
tion, xGlu immunoreactivity was detected in ciliary muscle 
(Figure 1G, H), corneal endothelial cells, cells of the anterior 
iris border (limiting) layer, iris thick walled blood vessels 
(Figure 1I, J), iris stromal melanocytes (Figure 1B, I, J), 
and pigmented cells/dilator muscle cells of the posterior iris 
(Figure 1A, B, I, J).
Detection of xGlu immunoreactivity 
in monkey ciliary body and iris tissue
XGlu immunoreactivity was detected in monkey ciliary 
body epithelial and iris cells (Figure 2). High concentrations 
of xGlu immunoreactivity were detected in monkey pars 
plicata ciliary body PE and NPE cells (Figure 2A, B). The 
intensity of the xGlu signal in monkey PE cells was similar 
to that in the adjacent NPE cells (Figure 2C, D). However, 
high concentrations of xGlu immunoreactivity were noted at 
the apical surface in several NPE cells (Figure 2C, D). XGlu 
immunoreactivity was also detected in the columnar NPE 
cells and cuboidal PE cells of the monkey pars plana tissue 
(Figure 2E, F). Also, high concentrations of xGlu immuno-
reactivity were detected in the monkey anterior iris pigment 
epithelial/dilator muscle cell layer along the posterior iris 
surface, in melanocytes within the iris stroma, and in endo-
thelial cells at the anterior surface of the iris (Figure 2G, H). 
Thus, these results suggest that the distribution of xGlu 
immunoreactivity is similar in human and monkey anterior 
uveal tissue.
Detection of GLAST-1 and GS in human 
uveal tissue by Western blot analysis
Based upon the detection of GLAST-1 and GS in retina 
(Kugler and Beyer 2003), the importance of GS to visual 
function (Barnett et al 2000) and regulation of Glu and am-
monia in the retina (Derouiche and Rauen 1995) as well as 
the detection of GS in rat retina and ciliary body (Riepe and 
Norenberg 1978), it was of interest to determine if GLAST-1 
and GS were expressed in human iris and ciliary body tissue. 
GLAST-1 and GS immunoreactive proteins were detected 
in iris, ciliary body, and retinal tissue lysates by western 
blot analysis (Figure 3). GLAST-1 (52 kDa) and GS (40 
kDa) protein bands were detected in iris, ciliary body, reti-
nal pigment epithelium (RPE), and nerve ﬁber layer (NFL) 
lysates. Higher molecular weight isoforms of GS (68, 72 
and/or 74 kDa) were detected in retinal tissue lysates (Figure 
3B). These results suggest that GLAST-1 and GS proteins are 
expressed in human iris, ciliary body, and retina tissue.
Co-localization of xGlu immunoreactivity, 
GLAST-1, and GS
Next, dual IFA analysis was employed to demonstrate the 
cellular localization of GLAST-1 with xGlu and GS with 
xGlu in human ciliary body tissue (Figure 4). Polyclonal 
antibody to a synthetic C-terminal peptide of rat GLAST-1 
reacted with corneal endothelial cells, iris melanocytes, iris Clinical Ophthalmology 2007:1(1) 47
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pigment epithelial/dilator muscle cells, and ciliary body PE 
and NPE cells (Figure 4A, B). Moreover, GLAST-1 was 
detected in the cytoplasm of PE and NPE cells, on the basal 
surface of PE cells, and on the apical and basal surfaces of 
NPE cells of the pars plicata (Figure 4D). GLAST-1 was 
also detected in the cytoplasm of cuboidal PE and columnar 
NPE cells, on the basal surface of the cuboidal PE cells, 
and on the apical and basal surfaces of the columnar NPE 
cells of the pars plana ciliary body (Figure 4G). GLAST-1 
was detected on pars plicata and pars plana ciliary body 
NPE cells that contained high concentrations of xGlu im-
munoreactivity (Figure 4C–H). Antibody to GS reacted with 
GS protein in the cytoplasm of xGlu positive PE and NPE 
cells and blood vessels (Figure 4I–K). These results suggest 
that human ciliary body PE and NPE cells contain xGlu, 
GLAST-1, and GS.
Serum/AH Gln,Ala, and Glu 
concentration gradients
The results of the studies above support the idea that GLAST1 
on NPE cell may actively remove Glu from the AH and 
that the transported Glu could be converted by GS to Gln 
in the presence of free ammonia as reported for retinal cells 
(Derouiche et al 1995; Shaked et al 2002). If so, one would 
predict that the Glu concentration in AH to be lower and the 
Gln concentration to be higher than in plasma. To assess the 
serum to AH concentration gradients, the Glu, Gln, and Ala 
concentrations in paired AH and serum samples from the 
monkeys and cataract patients were determined (Table 2). 
The mean Glu concentration (± standard deviation) in monkey 
AH (14 ± 5 nanamoles/ml; n = 10; was 3.2-fold lower than in 
serum (45 ± 14 nanamoles/ml; n = 5; p = 0.005), while the 
Glu concentration in cataractous AH (7.5 ± 4.6 nanamoles/ 
ml; n = 10) was 9.6 fold-lower than in paired human serum 
(72 ± 24 nanamoles/ml; n = 10; p < 0.001). Concomitantly, 
the AH Gln concentrations was higher than in paired serum 
from monkeys (587 ± 18 nanamoles/ml versus 392 ± 138 
nanamoles/ml; p = 0.01; S/AH ratio, 0.67:1) and humans 
(632 ± 132 nanamoles/ml versus 607 ± 91 nanamoles/ml; 
p = 0.15; S/AH ratio, 0.96:1). No differences were detected 
between Ala concentrations in paired monkey AH and serum 
samples (147 ± 27 nanamoles/ml versus 158 ± 39 nanamoles/ 
ml, respectively; S/AH ratio, 0.93:1) or in paired human AH 
and serum samples (255 ± 93 nanamoles/ml versus 232 ± 34 
nanamoles/ml, respectively; S/AH ratio, 0.91:1). The results 
suggest that the Glu concentration is lower, while the Gln 
concentration is higher in AH than serum and are consistent 
with Glu, Gln, and Ala concentrations reported in human and 
monkey AH (Reddy 1967; Reddy et al 1977; Wuu et al 1988; 
Dreyer et al 1996; Warmsley et al 2005). Taken together, the 
results support the possibility that the S/AH Glu and Gln 
gradients in human and monkey eyes may be due in part to 
uptake of Glu from the AH by ciliary body epithelial cells 
and release of Gln generated by GS.
Discussion
Immunoreactive xGlu was detected in the metabolically 
active cells that line the anterior and posterior chambers of 
human and monkey eyes. Accordingly, high levels of xGlu 
immunoreactivity were detected in cells lining the posterior 
cornea, anterior limiting, or border layer of the iris, cell bi-
layer at the posterior iris surface, PE and NPE cells lining the 
pars placata and pars plana ciliary body. In addition, xGlu 
immunoreactivity was detected in the branching pigment-
bearing melanocytes within the iris stroma, thick-walled iris 
blood vessels, iris pigment epithelial/dilator muscles, and cili-
ary muscle cells. Most notably, xGlu immunoreactivity was 
highly concentrated at the apical surface of ciliary body NPE 
cells. Interestingly, the distribution of xGlu immunoreactiv-
ity in NPE cells appeared to be similar to the distribution of 
pigment granule in PE cells (ie, a gradient across the cell with 
the highest concentrations on the apical side). The high con-
centration of xGlu immunoreactivity at the apical surface of 
NPE cells is likely fostered by the apical – apical apposition 
Table 2 Gln, Ala, and Glu concentrations in serum and AH from normal monkeys and inpatients with a cataractous (CAT) lens
Samples Serum (nanamoles/ml) AH (nanamoles/ml)
from: Glu Ala Gln Glu Ala Gln
Monkey (n=5)S/AH ratio 45 ± 14 147 ± 27 392 ± 138 14 ± 5b
3.2:1
158 ± 39
0.93:1
587 ± 18a
0.67:1
Hu CAT (n=10)S/AH ratio 72 ± 24 233 ± 34 607 ± 91 7.5 ± 4.6b
9.6:1
255 ± 93
0.91:1
632 ± 132
0.96:1
Note: Paired student test;ap  0.01;bp  0.005 
Abbreviations:   AH, aqueous humor; Ala, alanine; Gln, glutamine; Glu, glutamate; S, serum.Clinical Ophthalmology 2007:1(1) 48
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Figure 1 Distribution of xGlu immunoreactivity in anterior uveal tissues from human cadaver eyes. (A) Light photomicrograph of the inis/ciliary body (cb) of the #3 
human eye (Table 1) and corresponding (B) IFA photomicrograph showing xGlu immunoreactivity in epithelial cells that line the anterior and posterior iris and ciliary body. 
Note the intense immunoﬂuorescence staining of the ciliary process (cp) epithelial cells. (C) High magniﬁcation light photomicrograph of human ciliary body pars plicata 
tissue from the #2 donor eye and (D) corresponding IFA photomicrograph showing the intense xGlu immunoreactivity signal in NPE cells. (E) Higher magniﬁ cation light 
photomicrograph of human ciliary body tissue from the #1 donor eye and (F) the corresponding IFA photomicrograph showing intense xGlu immunoreactivity in PE and 
NPE cells (*). Note the highly intense immunoﬂuorescent signal at the apical surface of the NPE cells adjacent to the apical surface of the PE cells (large arrow). (G) Light 
photomicrograph of human pars plana tissue from the #3 donor eye and corresponding (H) IFA photomicrograph showing xGlu immunoreactivity in the columnar NPE 
(CoNPE) and cuboidal PE (CuPE) cells of the pars plana.Also, note the high concentration of xGlu immunoreactivity at the apical surface of the CoNPE cells and in ciliary 
smooth muscle (cm) cells of the #3 donor eye. (I) Light photomicrograph of #2 donor iris and the corresponding (J) IFA photomicrograph showing xGlu immunoreactivity 
in the cornea (co) cells, iris pigment epithelium and dilator muscle (dm) cell layer, thick walled blood vessels (bv), melanocytes of the vascular layer, and pigment cells on the 
anterior border of the iris surface. (Bar = 50 μm).
Abbreviations: bv, blood vessel; cb, ciliary body; cm, ciliary muscle; CoNPE, columnar NPE; cp, ciliary process; CuPE, cuboidal PE; cBM, cuticle layer of Bruch’s membrane; 
dm, dilator muscle; eBM, elastic layer of Bruch’s membrane; Gln, glutamine; IFA, immunoﬂuorescent-antibody; NPE, nonpigmented epithelial; PE, pigmented epithelial; xGlu, 
cross-linked glutamate.Clinical Ophthalmology 2007:1(1) 49
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Figure 2 Distribution of xGlu immunoreactivity in monkey ciliary body (cb) and iris tissue. (A) Light photomicrograph and (B) IFA showing xGlu immunoreactivity in the 
PE and NPE cells of #1 monkey pars plicata ciliary processes (cp). Note the higher concentration of xGlu immunoreactivity at the apical surface of some of the NPE cells 
(*). (C) Light photomicrograph of a high power magniﬁcation of a section of #2 monkey ciliary body tissue and (D) the corresponding IFA section showing xGlu immuno-
reactivity in PE and NPE cells with high concentration of xGlu immunoreactivity at the apices of some NPE cells (*). (E) Light photomicrograph of pars plana tissue and (F) 
the corresponding IFA showing a similar distribution of concentrated xGlu immunoreactivity in cuPE and coNPE cells (anterior to the elastic Brock’s membrane; eBM) as in 
para plana tissue. (G) Light photomicrograph of iris tissue and (H) corresponding IFA showing xGlu immunoreactivity in the anterior iris cells, iris melanocytes, blood vessel 
(bv) cells, and pigment containing epithelial/dilator muscle (dm) cells. (Bar = 50 mm).
Abbreviations: bv, blood vessel; cb, ciliary body; cm, ciliary muscle; CoNPE, columnar NPE; cp, ciliary process; CuPE, cuboidal PE; cBM, cuticle layer of Bruch’s membrane; 
dm, dilator muscle; eBM, elastic layer of Bruch’s membrane; Gln, glutamine; IFA, immunoﬂuorescent-antibody; NPE, nonpigmented epithelial; PE, pigmented epithelial; xGlu, 
cross-linked glutamate.
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of the PE and NPE cells (ie, in most cases amino acids are 
transported from the apical to basal surface) and could be due 
to several mechanism(s). That is, the xGlu immunoreactivity 
pattern in NPE cells could be due in part to Glu uptake by 
EAATs,Glu exchanger activity (Enkvist and McCarthy 1994; 
Schultz and Stell 1996), anaerobic glycolysis in ciliary body 
tissue (deRoetth 1954) or postmortem changes.
The detection of high afﬁnity GLAST-1 on cells that 
line the anterior chamber lumen (ie, corneal endothelium, 
iris melanocytes, and iris pigmented cells and ciliary body 
PE and NPE cells) suggests they may actively take up ex-
tracellular Glu as reported for GLAST-1 in brain, retinal, 
myocardial, and renal cells (Schultz and Stell 1996; Lehre 
et al 1997; Rauen et al 1998; Welbourne et al 2001; Ralphe 
et al 2004). Moreover, the high intracellular concentration 
of xGlu immunoreactivity in NPE cells and the lower than 
plasma concentration of AH Glu suggest that GLAST-1 on 
NPE cells may take up Glu from the AH. Notably, GLAST-
1 and xGlu immunoreactivity were detected in iris pigment 
epithelial/dilator muscle, ciliary body blood vessel wall, and 
ciliary muscle cells. The detection of GLAST-1 and xGlu 
immunoreactivity in iris and ciliary body muscles is consis-
tent with the reports of GLAST-1 and Glu in myocardium 
(Ralphe et al 2004) and of Glu in smooth muscle (Quesada 
et al 1993). Taken together, the results are consistent with 
the suggestion that GLAST-1 may play a role in maintain the 
high intracellular levels of Glu in human and monkey iris and 
ciliary body tissues, but they do not rule out the possibility 
that other EAATs may be present in human and monkey iris 
and ciliary body tissue. The likelihood that other EAAT are 
present is supported by the reports that different EAATs are 
associated with different cells within the retina (Schultz and 
Stell 1996; Arriza et al 1997; Pow et al 2000), all 5 EAAT 
subtypes are present in rat lens (Lim et al 2005), multiple 
EAATs may be expressed on a cell (Welbourne et al 2001; 
Ward et al 2004), EAAT2 has been detected in rabbit ciliary 
body (Langford et al 1997) and EAAT-3 has been detected in 
rat ciliary body tissue (Hu et al 2005). Further, the possibility 
that other Glu transport systems (Sweiry et al 1995; Bridges 
et al 2001) and alternate metabolic pathways (eg, leucine to 
Glu) (Schachter and Sang 2002) may also contribute to the 
high intracellular concentration of xGlu in human iris and 
ciliary body cells cannot be ruled out.
The detection of GS in PE and NPE cells suggests metabo-
lism of Glu to Gln in ciliary body tissue as in retina and kidney 
tissue (Riepe and Norenberg 1978; Welbourne et al 2001). 
Accordingly, Glu transported into the PE and NPE cell may 
be amidated by GS to form Gln. Moreover, the co-detection 
of GLAST-1 and GS in NPE cells supports the possibility 
that GLAST-1 and GS (Derouiche et al 1995; Shaked et al 
2002) may play a role in the regulation of Glu, ammonia and 
Gln within the ciliary body tissue and AH. Thus, the low Glu 
and high Gln levels in AH observed in this and previously 
studies (Reddy 1967; 1977; Wuu et al 1988) could be due in 
part by GLAST-1 and GS activity in ciliary body tissue. The 
importance of GS in ciliary body tissue, is further suggested 
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Figure 3 Western blot analysis for (A) GLAST-1 and (B) GS protein expression in iris, ciliary body (CB), retinal pigmented epithelium (RPE) and nerve ﬁber layer (NFL) 
tissues from 2 human cadaver eyes (5 μg protein/lane).
Abbreviations: GLAST-1, a glutamate transporter; GS, glutamine synthetase.Clinical Ophthalmology 2007:1(1) 51
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Figure 4 Distribution of GLAST-1 and GS with xGlu immunoreactivity in human anterior uveal tissue. (A) Light microscopy of a human iris and ciliary body (cb) tissue 
section from the #2 cadaver eye. (B). Fluorescent microscopy of the same tissue section showing intense GLAST-1 immunoreactivity in cornea endothelium (co), thick walled 
iris blood vessel (bv), iris pigment epithelium/dilator muscle cells (ipe), and PE and NPE cells that line the ciliary body (cb). (C) High magniﬁcation of ciliary body epithelia. 
(D) High power of the same section showing the distribution of immunoreactive GLAST-1 to the basal surface of PE and the basal and apical surfaces of NPE cells. (E) 
Corresponding high power magniﬁcation of the same section showing the distribution of xGlu immunoreactivity in PE and NPE cells with concentrated xGlu immunoreactiv-
ity localized to the apical side of NPE cells juxtaposed to the melanosome at the apical side of the PE cells. Note that GLAST-1 was detected on the basal PE and apical NPE 
surfaces and was associated with concentrated xGlu immunoreactivity (*) in NPE cells. (F) High power light microscopy of human pars plana ciliary body tissue. (G) Corre-
sponding ﬂ uorescent microscopy showing cuboidal PE (cuPE) and columnar NPE (coNPE) cells positive for GLAST-1. (H) Distribution of xGlu immunoreactivity in the same 
pars plana tissue section. (I) High power light microscopy of #3 donor ciliary body tissue with (J) corresponding ﬂuorescent microscopy showing blood vessels, PE and NPE 
cells positive for GS immuno  reactivity. (K) Distribution of xGlu immunoreactivity in the same section. Note that xGlu positive NPE cells were positive for GS (Bar = 50 μm).
Abbreviations: GLAST-1, a glutamate transporter; GS, glutamate synthetase; IFA, immunoﬂuorescent-antibody; NPE, nonpigmented epithelial; PE, pigmented epithelial; xGlu, 
cross-linked glutamate.
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by studies indicating that Glu is the source of Gln in rat 
ciliary body tissue (ie, inhibited by methionine sulfoximine) 
(Hu et al 2005).
The immunohistochemical detection of high levels of 
xGlu, GLAST-1, and GS ciliary body tissue supports the 
concept that perturbation of Glu levels or high afﬁ nity Glu 
transport activity can affect BAB permeability via the para-
cellular pathway between PE and NPE cells (Langford et al 
1997; 1999). The role of Glu in the paracellular permeability 
model (Langford et al 1997) is consistent with the reports that 
GLAST-1, GS, and/or Glu/Gln levels can modulate cell vol-
ume (Izumi et al 2004; Welbourne et al 2001), tight junction 
proteins (Li et al 2004), gap junction communication between 
cells (Enkvist and McCarthy 1994) and blood-retina barrier 
permeability (Frohlich and Klessen 2000). Additional studies 
are needed to assess the effects of different Glu transporters 
and GS on Glu levels in ciliary body tissue and on BAB 
paracellular permeability.
In summary, the distribution of xGlu immunoreactivity 
in the anterior uveal tissues of human and monkey eyes is 
similar. Notably, high levels of xGlu immunoreactivity were 
detected in GLAST-1 and GS positive ciliary body NPE 
cells. The low Glu and high Gln AH concentrations and 
the high concentration of Glu in GLAST-1 and GS positive 
NPE cells support the possibility that GLAST-1 (and other 
EAATs) and GS play a role in maintaining intracameral Glu 
gradients. Further, the results provide immunohistochemical 
support for the idea that pharmaceutical agents and systemic 
diseases that perturb Glu/Gln concentrations, GLAST-1, 
and/or GS activities may affect the barrier function of iris 
and ciliary body tissue.
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